Concurrent use of tamoxifen with CYP2D6 inhibitors and the risk of breast cancer recurrence

Author: Azoulay Laurent  

Publisher: Springer Publishing Company

ISSN: 0167-6806

Source: Breast Cancer Research and Treatment, Vol.126, Iss.3, 2011-04, pp. : 695-703

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content